Journal of Health And Care
Volume 26, Issue 2 (Summer 2024)
JHC 2024, 26(2): 196-206 |
Back to browse issues page
Ethics code: IR.IAU.KHUISF.REC.1402.238
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Bahoor S, Ziaeirad M. The Relationship between Stigma and Medication Adherence in Patients with Chronic Obstructive Pulmonary Disease Hospitalized in Razi Hospital in Rasht City. JHC 2024; 26 (2) :196-206
URL: http://hcjournal.arums.ac.ir/article-1-1555-en.html
URL: http://hcjournal.arums.ac.ir/article-1-1555-en.html
Community Health Research Center, Isfahan (Khorasgan) Branch, Islamic Azad University, Isfahan, IranDepartment of Nursing, School of Nursing and Midwifery, Isfahan (Khorasgan) Branch, Islamic Azad University, Isfahan, Iran
Abstract: (72 Views)
Background: Stigma, along with physical limitations due to respiratory symptoms of chronic obstructive pulmonary disease (COPD), can lead to social isolation and loneliness, poor self-management, and reduced engagement with health care providers. This study was conducted to determine the relationship between stigma and medication adherence in patients with COPD.
Methods: This correlational study was conducted on 140 patients with COPD hospitalized in Razi Hospital in Rasht city in 2023. Convenience sampling method was performed based on the inclusion criteria. Data collection tools were the demographic and clinical information form, Morisky Medication Adherence Questionnaire, and Stigma Scale for Chronic Diseases. The Data were analyzed using the Pearson correlation coefficient and multivariate regression model in SPSS-27 software.
Results: The mean of stigma score was 73.38±24.29 and the mean of medication adherence score was 2.67±2.61. Pearson correlation coefficient showed a negative and statistically significant relationship between medication adherence and stigma scores in COPD patients (p=-0.591, p<0.001). In addition, based on the results of multivariate linear regression analysis, stigma, and use of drug and inhaler can predict the medication adherence score.
Conclusion: Based on the results of this study, the stigma in COPD patients was moderate and medication adherence was poor. Furthermore, a significant inverse relationship was observed between medication adherence and stigma scores in these patients. Therefore, it is necessary to plan interventions to prevent stigma and control stigma-related factors, such as medication non-adherence, in COPD patients.
Methods: This correlational study was conducted on 140 patients with COPD hospitalized in Razi Hospital in Rasht city in 2023. Convenience sampling method was performed based on the inclusion criteria. Data collection tools were the demographic and clinical information form, Morisky Medication Adherence Questionnaire, and Stigma Scale for Chronic Diseases. The Data were analyzed using the Pearson correlation coefficient and multivariate regression model in SPSS-27 software.
Results: The mean of stigma score was 73.38±24.29 and the mean of medication adherence score was 2.67±2.61. Pearson correlation coefficient showed a negative and statistically significant relationship between medication adherence and stigma scores in COPD patients (p=-0.591, p<0.001). In addition, based on the results of multivariate linear regression analysis, stigma, and use of drug and inhaler can predict the medication adherence score.
Conclusion: Based on the results of this study, the stigma in COPD patients was moderate and medication adherence was poor. Furthermore, a significant inverse relationship was observed between medication adherence and stigma scores in these patients. Therefore, it is necessary to plan interventions to prevent stigma and control stigma-related factors, such as medication non-adherence, in COPD patients.
Type of Study: article |
Subject:
nursing
Received: 2024/03/27 | Accepted: 2024/07/31 | Published: 2024/07/31
Received: 2024/03/27 | Accepted: 2024/07/31 | Published: 2024/07/31
References
1. Roman-Rodriguez M, Kaplan A. GOLD 2021 strategy report: implications for asthma-COPD overlap. International Journal of Chronic Obstructive Pulmonary Disease. 2021;16:1709-15. [DOI:10.2147/COPD.S300902] [PMID] []
2. Soriano JB, Kendrick PJ, Paulson KR, Gupta V, Abrams EM, Adedoyin RA, et al. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet Respiratory Medicine. 2020;8(6):585-96. [DOI:10.1016/S2213-2600(20)30105-3] [PMID]
3. Sharifi H, Ghanei M, Jamaati H, Masjedi MR, Aarabi M, Sharifpour A, et al. Burden of obstructive lung disease study in Iran: first report of the prevalence and risk factors of COPD in five provinces. Lung India. 2019;36(1):14-19. [DOI:10.4103/lungindia.lungindia_129_18] [PMID] []
4. Prasad B. Chronic Obstructive Pulmonary Disease (COPD). International Journal of Pharmacy Research & Technology. 2020;10(1):67-71.
5. Pelgrim CE, Peterson JD, Gosker HR, Schols AM, van Helvoort A, Garssen J, et al. Psychological co-morbidities in COPD: targeting systemic inflammation, a benefit for both? European Journal of Pharmacology. 2019;842:99-110. [DOI:10.1016/j.ejphar.2018.10.001] [PMID]
6. Woo S, Larson J. Evaluating and refining a preliminary stigma questionnaire for people with chronic obstructive pulmonary disease (COPD): a cognitive interviewing study. C24 enhancing the treatment environment to improve patient and caregiver outcomes. American Thoracic Society. 2019;199:A4367. [DOI:10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A4367]
7. World Health Organization. Social stigma associated with COVID-19: a guide to preventing and addressing social stigma. Geneva: WHO Press; 2020.
8. Bruns DP, Kraguljac NV, Bruns TR. COVID-19: facts, cultural considerations, and risk of stigmatization. Journal of Transcultural Nursing. 2020;31(4):326-32. [DOI:10.1177/1043659620917724] [PMID] []
9. Mahdilouy P, Ziaeirad M. Relationship between perceived social stigma and diabetes self-care activities in Iranian participants with type 1 diabetes. Journal of Diabetes & Metabolic Disorders. 2021;20:1505-11. [DOI:10.1007/s40200-021-00893-1] [PMID] []
10. Yamamura T. Are people with chronic obstructive pulmonary disease prone to stigma in any culture? from a qualitative study in Japan. International Journal of Medical and Health Research. 2023;9(3):8-13.
11. Woo S, Veliz P, Saint Arnault DM, Struble LM, Earl A, Larson JL. Development and preliminary psychometric evaluation of the COPD-related stigma scale. Heart & Lung. 2023;61:22-28. [DOI:10.1016/j.hrtlng.2023.04.006] [PMID]
12. Rose S, Paul C, Boyes A, Kelly B, Roach D. Stigma-related experiences in non-communicable respiratory diseases: a systematic review. Chronic Respiratory Disease. 2017;14(3):199-216. [DOI:10.1177/1479972316680847] [PMID] []
13. Masumoto S, Sato M, Momo K, Matsushita A, Suzuki K, Shimamura H, et al. Development of medication regimen complexity index: Japanese version and application in elderly patients. International Journal of Clinical Pharmacy. 2021;43:858-63. [DOI:10.1007/s11096-020-01185-z] [PMID]
14. Horvat N, Locatelli I, Kos M, Janežič A. Medication adherence and health-related quality of life among patients with chronic obstructive pulmonary disease. Acta Pharmaceutica. 2018;68(1):117-25. [DOI:10.2478/acph-2018-0006] [PMID]
15. Bhattarai B, Walpola R, Mey A, Anoopkumar-Dukie S, Khan S. Barriers and strategies for improving medication adherence among people living with COPD: a systematic review. Respiratory Care. 2020;65(11):1738-50. [DOI:10.4187/respcare.07355] [PMID]
16. Biswas D, Mukherjee S, Chakroborty R, Chatterjee S, Rath S, Das R, et al. Occurrence of anxiety and depression among stable COPD patients and its impact on functional capability. Journal of Clinical and Diagnostic Research. 2017;11(2):OC24. [DOI:10.7860/JCDR/2017/24203.9393] [PMID] []
17. van de Hei SJ, Dierick BJ, Aarts JE, Kocks JW, van Boven JF. Personalized medication adherence management in asthma and chronic obstructive pulmonary disease: a review of effective interventions and development of a practical adherence toolkit. The Journal of Allergy and Clinical Immunology: In Practice. 2021;9(11):3979-94. [DOI:10.1016/j.jaip.2021.05.025] [PMID]
18. Krousel-Wood M, Islam T, Webber LS, Re R, Morisky DE, Muntner P. New medication adherence scale versus pharmacy fill rates in hypertensive seniors. The American Journal of Managed Care. 2009;15(1):59.
19. Ghanei Gheshlagh R, Ebadi A, Veisi Raygani AK, Nourozi Tabrizi K, Dalvandi A, Mahmoodi H. Determining concurrent validity of the Morisky Medication Adherence Scale in patients with type 2 diabetes. Iranian Journal of Rehabilitation Research in Nursing. 2015;1(3):24-32. [Persian]
20. Rao D, Choi SW, Victorson D, Bode R, Peterman A, Heinemann A, et al. Measuring stigma across neurological conditions: the development of the stigma scale for chronic illness (SSCI). Quality of Life Research. 2009;18(5):585-95. [DOI:10.1007/s11136-009-9475-1] [PMID] []
21. Zahraie S, Amini S, Saebi S. The relationship between illness perception, stigma and cognitive fusion with quality of life of the women with multiple sclerosis. Journal of Psychological Studies. 2018;14(2):25-40. [Persian]
22. Woo S, Zhou W, Larson JL. Stigma experiences in people with chronic obstructive pulmonary disease: an integrative review. International Journal of Chronic Obstructive Pulmonary Disease. 2021;16:1647-59. [DOI:10.2147/COPD.S306874] [PMID] []
23. Brighton LJ, Chilcot J, Maddocks M. Social dimensions of chronic respiratory disease: stigma, isolation, and loneliness. Current Opinion in Supportive and Palliative Care. 2022;16(4):195-202. [DOI:10.1097/SPC.0000000000000616] [PMID]
24. Mahdilouy P, Ziaeirad M. Perceived social stigma and its relationship with demographic and clinical characteristics in adolescents and young people with type 1 diabetes. Iranian Journal of Endocrinology and Metabolism. 2019;21(3):153-62. [Persian]
25. Abdollahi F, Biglar S, Shojaei F, Puryaghoob M. Assessment of stigma and self-esteem in female adults with type I diabetes in Tehran, Iran. Journal of Diabetes Nursing. 2019;7:704-13. [Persian]
26. Rasoolinajad M, Abedinia N, Noorbala AA, Mohraz M, Moradmand B. Effect of mental health, coping mechanisms and stigma on risky behaviors in HIV positive patients in Iran: a cross-sectional study. Razi Journal of Medical Sciences. 2017;24:83-93. [Persian]
27. Kheftan P, Jam FG, Amirpour B, Arshi M, Eghlima M, Rahgozar M. Predicting epilepsy-related stigma based on health-related life style components. Iran Journal of Nursing Research. 2018;13(4):72-78. [Persian]
28. Ahmad H, Jabeen N, Iqbal S, Farooqi RJ, Ashraf S. Adherence to inhaler medications in patients treated for Asthma and COPD. Pakistan Journal of Chest Medicine. 2018;24(1):17.
29. Rogliani P, Ora J, Puxeddu E, Matera MG, Cazzola M. Adherence to COPD treatment: myth and reality. Respiratory Medicine. 2017;129:117-23. [DOI:10.1016/j.rmed.2017.06.007] [PMID]
30. Rai SS, Syurina EV, Peters RM, Putri AI, Zweekhorst MB. Non-communicable diseases-related stigma: a mixed-methods systematic review. International Journal of Environmental Research and Public Health. 2020;17(18):6657. [DOI:10.3390/ijerph17186657] [PMID] []
31. Madawala S, Osadnik CR, Warren N, Kasiviswanathan K, Barton C. Healthcare experiences of adults with COPD across community care settings: a meta-ethnography. ERJ Open Research. 2023;9(1):00581-2022. [DOI:10.1183/23120541.00581-2022] [PMID] []
32. Ágh T, Dömötör P, Bártfai Z, Inotai A, Fujsz E, Mészáros Á. Relationship between medication adherence and health-related quality of life in subjects with COPD: a systematic review. Respiratory Care. 2015;60(2):297-303. [DOI:10.4187/respcare.03123] [PMID]
33. Miravitlles M, Marín A, Huerta A, Carcedo D, Villacampa A, Puig-Junoy J. Estimation of the clinical and economic impact of an improvement in adherence based on the use of once-daily single-inhaler triple therapy in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease. 2020:1643-54. [DOI:10.2147/COPD.S253567] [PMID] []
34. Federman AD, O'conor R, Wolf MS, Wisnivesky JP. Associations of medication regimen complexity with COPD medication adherence and control. International Journal of Chronic Obstructive Pulmonary Disease. 2021:2385-92. [DOI:10.2147/COPD.S310630] [PMID] []
35. Divo M, Celli BR. Multimorbidity in patients with chronic obstructive pulmonary disease. Clinical Chest Medicine. 2020;41(3):405-19. [DOI:10.1016/j.ccm.2020.06.002] [PMID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |